rs61750246

Variant summary

Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2

The NM_001110792.2(MECP2):​c.1197C>T​(p.Pro399=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000122 in 1,088,399 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 48 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. P399P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000064 ( 0 hom., 2 hem., cov: 21)
Exomes 𝑓: 0.00012 ( 0 hom. 48 hem. )
Failed GnomAD Quality Control

Consequence

MECP2
NM_001110792.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 1.27
Variant links:
Genes affected
MECP2 (HGNC:6990): (methyl-CpG binding protein 2) DNA methylation is the major modification of eukaryotic genomes and plays an essential role in mammalian development. Human proteins MECP2, MBD1, MBD2, MBD3, and MBD4 comprise a family of nuclear proteins related by the presence in each of a methyl-CpG binding domain (MBD). Each of these proteins, with the exception of MBD3, is capable of binding specifically to methylated DNA. MECP2, MBD1 and MBD2 can also repress transcription from methylated gene promoters. In contrast to other MBD family members, MECP2 is X-linked and subject to X inactivation. MECP2 is dispensible in stem cells, but is essential for embryonic development. MECP2 gene mutations are the cause of most cases of Rett syndrome, a progressive neurologic developmental disorder and one of the most common causes of cognitive disability in females. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -17 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BP6
Variant X-154030667-G-A is Benign according to our data. Variant chrX-154030667-G-A is described in ClinVar as [Benign]. Clinvar id is 95186.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154030667-G-A is described in Lovd as [Likely_benign]. Variant chrX-154030667-G-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=1.27 with no splicing effect.
BS2
High Hemizygotes in GnomAdExome4 at 48 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
MECP2NM_001110792.2 linkuse as main transcriptc.1197C>T p.Pro399= synonymous_variant 3/3 ENST00000453960.7
MECP2NM_004992.4 linkuse as main transcriptc.1161C>T p.Pro387= synonymous_variant 4/4 ENST00000303391.11

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
MECP2ENST00000453960.7 linkuse as main transcriptc.1197C>T p.Pro399= synonymous_variant 3/31 NM_001110792.2 P51608-2
MECP2ENST00000303391.11 linkuse as main transcriptc.1161C>T p.Pro387= synonymous_variant 4/41 NM_004992.4 P1P51608-1
MECP2ENST00000407218.5 linkuse as main transcriptc.*533C>T 3_prime_UTR_variant 4/45
MECP2ENST00000628176.2 linkuse as main transcriptc.*533C>T 3_prime_UTR_variant 5/53

Frequencies

GnomAD3 genomes
AF:
0.00
AC:
7
AN:
108851
Hom.:
0
Cov.:
21
AF XY:
0.0000642
AC XY:
2
AN XY:
31143
FAILED QC
Gnomad AFR
AF:
0.0000671
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000195
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000384
Gnomad OTH
AF:
0.000685
GnomAD3 exomes
AF:
0.000156
AC:
27
AN:
172947
Hom.:
0
AF XY:
0.000158
AC XY:
10
AN XY:
63223
show subpopulations
Gnomad AFR exome
AF:
0.0000869
Gnomad AMR exome
AF:
0.000147
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000733
Gnomad SAS exome
AF:
0.000212
Gnomad FIN exome
AF:
0.000379
Gnomad NFE exome
AF:
0.000156
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000122
AC:
133
AN:
1088399
Hom.:
0
Cov.:
35
AF XY:
0.000135
AC XY:
48
AN XY:
356397
show subpopulations
Gnomad4 AFR exome
AF:
0.0000381
Gnomad4 AMR exome
AF:
0.000114
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000332
Gnomad4 SAS exome
AF:
0.000111
Gnomad4 FIN exome
AF:
0.000326
Gnomad4 NFE exome
AF:
0.000123
Gnomad4 OTH exome
AF:
0.000109
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0000643
AC:
7
AN:
108851
Hom.:
0
Cov.:
21
AF XY:
0.0000642
AC XY:
2
AN XY:
31143
show subpopulations
Gnomad4 AFR
AF:
0.0000671
Gnomad4 AMR
AF:
0.000195
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000384
Gnomad4 OTH
AF:
0.000685
Alfa
AF:
0.0000434
Hom.:
0
Bravo
AF:
0.0000869

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Rett syndrome Benign:3
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpDec 01, 2015- -
Benign, criteria provided, single submitterclinical testingMolecular Genetics Laboratory, Children's Mercy Hospital and Clinics-- -
Benign, criteria provided, single submittercurationCentre for Population Genomics, CPGMar 14, 2024This variant has been collected from RettBASE and curated to current modified ACMG/AMP criteria. Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders Specifications to the ACMG/AMP Variant Interpretation Guidelines VCEP 3.0, this variant is classified as benign. At least the following criteria are met: The allele frequency of this variant in at least one population in gnomAD is higher than the 0.03% threshold defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders VCEP 3.0 (BA1). -
not provided Benign:3
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Benign, criteria provided, single submitterclinical testingGeneDxMar 03, 2015- -
Likely benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
not specified Benign:2
Benign, no assertion criteria providedcurationRettBASENov 01, 2011- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Mar 08, 2013- -
Severe neonatal-onset encephalopathy with microcephaly Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeJan 24, 2024- -
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsNov 14, 2018This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.63
CADD
Benign
4.0
DANN
Benign
0.47

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs61750246; hg19: chrX-153296118; COSMIC: COSV57656782; COSMIC: COSV57656782; API